Cargando…
Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies
Human monoclonal antibodies (mAbs) against the central repeat and junction domain of Plasmodium falciparum circumsporozoite protein (PfCSP) have been studied extensively to guide malaria vaccine design compared to antibodies against the PfCSP C terminus. Here, we describe the molecular characteristi...
Autores principales: | Oludada, Opeyemi Ernest, Costa, Giulia, Burn Aschner, Clare, Obraztsova, Anna S, Prieto, Katherine, Canetta, Caterina, Hoffman, Stephen L, Kremsner, Peter G, Mordmüller, Benjamin, Murugan, Rajagopal, Julien, Jean‐Philippe, Levashina, Elena A, Wardemann, Hedda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245032/ https://www.ncbi.nlm.nih.gov/pubmed/37082831 http://dx.doi.org/10.15252/emmm.202317454 |
Ejemplares similares
-
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
por: Scally, Stephen W., et al.
Publicado: (2018) -
A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity
por: Thai, Elaine, et al.
Publicado: (2020) -
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023) -
Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023) -
How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein
por: Wahl, Ilka, et al.
Publicado: (2022)